60 Degrees Pharmaceuticals Updates ATM Program, Discloses $1.39M in Prior Sales and $1.3M Remaining Capacity

summarizeSummary

60 Degrees Pharmaceuticals updated its At-The-Market (ATM) offering, revealing it has already sold $1.39 million in stock and has an additional $1.3 million available to sell, representing substantial potential dilution for the micro-cap company.

check_boxKey Events

• ATM Program Update

  The company amended its At-The-Market (ATM) offering program, allowing it to sell up to an additional $1,308,000 in common stock from time to time through H.C. Wainwright & Co., LLC.

• Prior Share Sales Disclosed

  60 Degrees Pharmaceuticals disclosed that it has already sold 555,593 shares under the ATM program for aggregate gross proceeds of $1,396,091 as of the date of this prospectus supplement.

• Capital Raise Context

  This capital raise follows the company's 1-for-4 reverse stock split on January 20, 2026, and its recent regaining of Nasdaq compliance on February 12, 2026, after receiving a delisting notice in January 2026.

auto_awesomeAnalysis

This filing updates an existing At-The-Market (ATM) offering program, revealing that 60 Degrees Pharmaceuticals has already sold $1.39 million worth of common stock and has authorized an additional $1.308 million for future sales. For a company with a market capitalization of approximately $3.2 million, these amounts represent significant potential dilution. The capital raised is crucial for the company, especially following its recent reverse stock split and successful efforts to regain Nasdaq compliance, indicating an ongoing need for operational funding.